Skip to main content
Equibles

Christopher Wetzel

Board Member

Sigyn Therapeutics, Inc. (SIGY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher Wetzel

Christopher Wetzel is recorded as Board Member at Sigyn Therapeutics, Inc. (SIGY). Sigyn Therapeutics, Inc. reported in an 8-K filed August 15, 2025 that Christopher Wetzel resigned as Board of Directors, effective August 7, 2025. Sigyn Therapeutics, Inc. reported in an 8-K filed October 5, 2022 that Christopher Wetzel was appointed Director, effective October 10, 2022.

“On August 7, 2025, Christopher Wetzel notified the Company of his decision to resign from the Board of Directors, effective August 7, 2025.”
Sigyn Therapeutics, Inc. Form 8-K, filed August 15, 2025 · Read the filing
“The Board of Directors of Sigyn Therapeutics, Inc. ("the Company") appointed Jim Dorst, Richa Nand, and Christopher Wetzel to the Company's Board of Directors effective as of October 10, 2022.”
Sigyn Therapeutics, Inc. Form 8-K, filed October 5, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Sigyn Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.